The United Laboratories International Holdings Limited (ULIHF)

Market Cap	2.29B -39.9%
Revenue (ttm)	1.89B -4.0%
Net Income	298.22M -21.6%
EPS	0.16 -24.4%
Shares Out	n/a
PE Ratio	7.67
Forward PE	11.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	1.240
Previous Close	1.240
Day's Range	1.240 - 1.240
52-Week Range	1.175 - 2.277
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About ULIHF

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products; insulin series, antibiotics, and ophthalmic products; and veterinary drugs. It also provides 6-aminopenicillanic acid and penicillin G potassium products. In addition, the company provides endocrine and metabolism, anti-...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 18,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: ULIHF

Financial Performance

In 2025, ULIHF's revenue was 13.21 billion, a decrease of -3.99% compared to the previous year's 13.76 billion. Earnings were 2.09 billion, a decrease of -21.57%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 11, 2026

Data Sources Report a data error